Application of natural zeolite adsorption in cooperation with photosynthesis for the post-treatment of microbial fuel cells.

Microbial fuel cells (MFCs) are a promising technology that directly converts organic matter (OM) in wastewater into electricity while simultaneously degrading contaminants. However, MFCs are insufficient for the removal of nitrogenous compounds. Therefore, the post-treatment of MFCs is essential. This study was the first to use natural zeolite adsorption integrated with photosynthesis (ZP) for post-treating MFCs. In this system, no external energy was required; instead, natural light was used to promote the growth of photosynthetic microorganisms, thereby enhancing contaminants removal through the photosynthesis process. To assess the effectiveness of the method, comparisons were conducted under two conditions: dark (no photosynthesis) and light (with photosynthesis). In darkness, extending hydraulic retention time (HRT) enhanced COD and BOD removal by 19.8% and 28.9%, respectively. When exposed to natural light, improvements were even more notable, with COD and BOD removal reaching 32% and 40%, respectively. In both conditions, the method effectively removed NH4 +, achieving 60% efficiency in darkness and 84.5% in light. This study showed that the adsorption capacity of the zeolite reached saturation when the cumulative liquid volume per unit weight of the zeolite exceeded 0.2 L g-1. The key functional photosynthetic microbes were investigated using 16S rRNA and 18S rRNA. This revealed the presence of microorganisms such as Chlorobium, Acidovorax, Novosphingobium, and Scenedesmus, which likely play a role in enhancing the efficiency of photosynthesis in removing contaminants. The study findings indicated that the integration of MFCs-ZP represents an eco-friendly approach capable of resource recovery from wastewater while also meeting discharge standards.

Survey of Entamoeba infections in schoolchildren and macaques in Kathmandu, Nepal, and analysis of genetic polymorphisms of Entamoeba nuttalli and Entamoeba dispar isolates.

Entamoeba species infect humans and non-human primates, raising concerns associated with potential zoonotic transmission. Therefore, the prevalence of human Entamoeba infections is crucial for its management in areas, where macaques exhibit high infection rates. Previously, we demonstrated prevalent E. nuttalli infections in rhesus macaques in Kathmandu, Nepal. In this study, we surveyed Entamoeba infection among 185 schoolchildren from two schools visited by wild rhesus macaques to assess the risk of transmission. PCR-based screening for Entamoeba species identified E. coli in 13 % and E. dispar in 0.5 % of the human stool samples. However, E. nuttalli and E. chattoni infections, prevalent in macaques, were not detected in human samples. This suggests that Entamoeba spp. are not transmitted through macaques in the school environment. We surveyed the rhesus macaques living in the temple near schools as well as the rhesus and Assam macaques inhabiting Shivapri Nagarjun National Park, Kathmandu. Among the 49 macaque stool samples, E. chattoni, E. coli, E. nuttalli, and E. dispar were detected in 92 %, 86 %, 41 %, and 18 % of the samples, respectively. Notably, E. dispar infections in macaques were mostly prevalent in the temple. A sample isolated from Nagarujun showed an identical genotype at two tRNA-linked short tandem repeat loci to that of E. dispar isolated from humans, suggesting potential transmission from humans to macaques. Genotypic analysis of cultured E. nuttalli strains obtained from the macaques colonizing three locations demonstrated that the geographical distance rather than differences in macaque species played a crucial role in the genetic diversity of the parasites. The phylogenetic tree of E. nuttalli strains, including the previously isolated strains, reflected the geographical distribution of the isolation sites. This study sheds light on the intricate dynamics of Entamoeba transmission and genetic diversity in macaques and humans.

Microbial fuel cell in long-term operation and providing electricity for intermittent aeration to remove contaminants from sewage.

Microbial fuel cells (MFCs) show promise in sewage treatment because they can directly convert organic matter (OM) into electricity. This study aimed to demonstrate MFCs stability over 750 days of operation and efficient removal of OM and nitrogenous compounds from sewage. To enhance contaminant removal, oxygen was provided into the anode chamber via a mini air pump. This pump was powered by the MFCs' output voltage, which was boosted using a DC-DC converter. The experimental system consisted of 12 sets of cylindrical MFCs within a 246L-scale reactor. The boosted voltage reached 4.7 V. This voltage was first collected in capacitors every 5 min and then dispensed intermittently to the air pump for the MFCs reactor in 4 s. This corresponds to receiving average DO concentration reaching 0.34 ± 0.44 mg/L at 10 cm above the air-stone. Consequently, the degradation rate constants (k) for chemical oxygen demand (COD) and biological oxygen demand (BOD) in the presence of oxygen were 0.048 and 0.069, respectively, which surpassed those without oxygen by 0.039 and 0.044, respectively. Aeration also marginally improved the removal of ammonia because of its potential to create a favorable environment for the growth of anammox and ammonia-oxidizing bacteria such as Candidatus brocadia and Nitrospira. The findings of this study offer in-depth insight into the benefits of boosted voltage in MFCs, highlighting its potential to enhance contaminant degradation. This serves as a foundation for future research focused on improving MFCs performance, particularly for the removal of contaminants from wastewater.

Preliminary evaluation of electricity recovery from palm oil mill effluent by anion exchange microbial fuel cell.

This study assessed the viability of an anion-exchange microbial fuel cell (MFC) for extracting electricity from palm oil mill effluent (POME), a major pollutant in palm-oil producing regions due to increasing demand. The MFC incorporated a tubular membrane electrode assembly (MEA) with an air core, featuring a carbon-painted carbon-cloth cathode, an anion exchange membrane (AEM), and a nonwoven graphite fabric (NWGF) anode. An additional carbon brush (CB) anode was placed adjacent to the tubular MEA. The MFC operated under semi-batch conditions with POME replacement every 7 days. Results showed superior performance of the AEM, with the highest power density (Pmax) observed in POME-treated MFCs. Current and power density increased with CB addition; the best chemical oxygen demand (COD) removal efficiency reached 73 %, decreasing from 1249 to 332 mg/L with three CBs. The Pmax was 0.18 W/m-2(-|-) with 1000 mg/L COD and three CBs, dropping to 0.0031 W/m-2(-|-) without CB and at 410 mg/L COD. Anode resistance, calculated using organic matter supplementation, COD, and anode surface area, decreased with increased COD or surface area, improving electricity production. AEM and CB compatibility synergistically enhanced MFC performance, offering potential for POME wastewater treatment and energy recovery.

Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.

The existence of substandard and falsified medicines threatens people's health and causes economic losses as well as a loss of trust in medicines. As the distribution of pharmaceuticals becomes more globalized and the spread of substandard and falsified medicines continues worldwide, pharmaceutical security measures must be strengthened. To eradicate substandard and falsified medicines, our group is conducting fact-finding investigations of medicines distributed in lower middle-income countries (LMICs) and on the Internet. From the perspective of pharmaceutics, such as physical assessment of medicines, we are working to clarify the actual situation and develop methods to detect substandard and falsified medicines. We have collected substandard and falsified medicines distributed in LMICs and on the Internet and performed pharmacopoeial tests, mainly using HPLC, which is a basic analytic method. In addition to quality evaluation, we have evaluated the applicability of various analytic methods, including observation of pharmaceuticals using an electron microscope, Raman scattering analysis, near-IR spectroscopic analysis, chemical imaging, and X-ray computed tomography (CT) to detect substandard and falsified medicines, and we have clarified their limitations. We also developed a small-scale quality screening method using statistical techniques. We are engaged in the development of methods to monitor the distribution of illegal medicines and evolve research in forensic and policy science. These efforts will contribute to the eradication of substandard and falsified medicines. Herein, I describe our experience in the development of detection methods and elucidation of the pharmaceutical status of substandard and falsified medicines using novel technologies.

A longer-chain acylated derivative of Dictyostelium differentiation-inducing factor-1 enhances the antimalarial activity against Plasmodium parasites.

The spread of malarial parasites resistant to first-line treatments such as artemisinin combination therapies is a global health concern. Differentiation-inducing factor 1 (DIF-1) is a chlorinated alkylphenone (1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl) hexan-1-one) originally found in the cellular slime mould Dictyostelium discoideum. We previously showed that some derivatives of DIF-1, particularly DIF-1(+2) (1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl) octan-1-one), exert potent antimalarial activities. In this study, we synthesised DIF-1(+3) (1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl) nonan-1-one). We then evaluated the effects of DIF-1(+3) in vitro on Plasmodium falciparum and in vivo over 7 days (50-100 mg/kg/day) in a mouse model of Plasmodium berghei. DIF-1(+3) exhibited a half-maximal inhibitory concentration of approximately 20-30 % of DIF-1(+2) in three laboratory strains with a selectivity index > 263, including in strains resistant to chloroquine and artemisinin. Parasite growth and multiplication were almost completely suppressed by treatment with 100 mg/kg DIF-1(+3). The survival time of infected mice was significantly increased (P = 0.006) with no apparent adverse effects. In summary, addition of an acyl group to DIF-1(+2) to prepare DIF-1(+3) substantially enhanced antimalarial activity, even in drug-resistant malaria, indicating the potential of applying DIF-1(+3) for malaria treatment.

Detection of drug-resistant malaria in resource-limited settings: efficient and high-throughput surveillance of artemisinin and partner drug resistance.

OBJECTIVES: Artemisinin-resistant Plasmodium falciparum malaria is currently spreading globally, including in Africa. Artemisinin resistance also leads to resistance to partner drugs used in artemisinin-based combination therapies. Sequencing of kelch13, which is associated with artemisinin resistance, culture-based partner drug susceptibility tests, and ELISA-based growth measurement are conventionally used to monitor resistance; however, their application is challenging in resource-limited settings. METHODS: An experimental package for field studies with minimum human/material requirements was developed. RESULTS: First, qPCR-based SNP assay was applied in artemisinin resistance screening, which can detect mutations within 1 h and facilitate sample selection for subsequent processes. It had 100% sensitivity and specificity compared with DNA sequencing in the detection of the two common artemisinin resistance mutations in Uganda, C469Y and A675V. Moreover, in the partner drug susceptibility test, the cultured samples were dry-preserved on a 96-well filter paper plate and shipped to the central laboratory. Parasite growth was measured by ELISA using redissolved samples. It well reproduced the results of direct ELISA, reducing significant workload in the field (Pearson correlation coefficient: 0.984; 95% CI: 0.975-0.990). CONCLUSIONS: Large-scale and sustainable monitoring is required urgently to track rapidly spreading drug-resistant malaria. In malaria-endemic areas, where research resources are often limited, simplicity and feasibility of the procedure is especially important. Our approach combines a qPCR-based rapid test, which is also applicable to point-of-care diagnosis of artemisinin resistance and centralized analysis of ex vivo culture. The approach could improve efficiency of field experiments and accelerate global drug resistance surveillance.

Human ocular thelaziasis with genetic analysis in Niigata Prefecture, Japan: A case report on an emerging zoonosis.

Purpose: We report the clinical findings and molecular identification of ocular Thelazia callipaeda from Niigata Prefecture in the Hokuriku area of Japan during winter. Observations: A 77-year-old male visited an ophthalmology clinic in Niigata Prefecture in January 2022 after a 2-week-duration of a conjunctival injection in the left eye and foreign body sensation. Slit-lamp microscopy revealed 11 active nematodes in the left conjunctival sac. Morphological characteristics included longer female body length than male, buccal cavity lacking teeth and lips, and serrated striations along the body surface. The specimens were determined to be T. callipaeda. Genetic analysis of the mitochondrial cytochrome c oxidase subunit 1 (cox1) gene revealed an h9 haplotype. Conclusions and Importance: T. callipaeda infection, especially the h9 haplotype, commonly occurs in western Japan owing to its higher incidence in warmer climates, suggesting the origin of the case. Here, we report a human case of Thelaziasis diagnosed in a cold region of Japan (the Hokuriku area) during winter. This human case of T. callipaeda infection from a cold, previously unassociated region, raises concerns about the potential geographical widening of its distribution, and further investigation may be warranted to prevent its spread.

Degradation rates and products of fluticasone propionate in alkaline solutions / 药物分析学报

The apparent degradation rate constant of fluticasone propionate (FLT) in 0.1 M NaOH:methanol=1:1 at 37 ℃ was previously reported to be 0.169 ± 0.003 h?1, and four degradation products (products 1–4) were observed in the solution. The aims of the present study were to assess the degradation rates of FLT in other alkaline solutions and clarify the chemical structures of the four degradation products in order to obtain basic data for designing an enema for inflammatory bowel disease. The apparent degradation rate constants in 0.05 M NaOH and 0.1 M NaOH:CH3CN=1:1 were 0.472 ± 0.013 h?1 and 0.154 ± 0.000 h?1 (n=3), respectively. The chemical structures of products 1–4 in 0.1 M NaOH:methanol=1:1 were revealed by nuclear magnetic resonance (NMR) and mass spectrometry data. The chemical structure of products 2 was that the 17-position of the thioester moiety of FLT was substituted by a carboxylic acid. The degradation product in 0.1 M NaOH:CH3CN=1:1 was found to be product 2 based on 1H NMR data. The degradation product in 0.05 M NaOH was considered to be product 2 based on the retention time of HPLC. These results are useful for detecting the degradation products of FLT by enzymes of the intestinal bacterial flora in the large intestine after dosing FLT as an enema.

Degradation rates and products of fluticasone propionate in alkaline solutions / 药物分析学报

The apparent degradation rate constant of fluticasone propionate (FLT) in 0.1 M NaOH:methanol=1:1 at 37 ℃ was previously reported to be 0.169 ± 0.003 h?1, and four degradation products (products 1–4) were observed in the solution. The aims of the present study were to assess the degradation rates of FLT in other alkaline solutions and clarify the chemical structures of the four degradation products in order to obtain basic data for designing an enema for inflammatory bowel disease. The apparent degradation rate constants in 0.05 M NaOH and 0.1 M NaOH:CH3CN=1:1 were 0.472 ± 0.013 h?1 and 0.154 ± 0.000 h?1 (n=3), respectively. The chemical structures of products 1–4 in 0.1 M NaOH:methanol=1:1 were revealed by nuclear magnetic resonance (NMR) and mass spectrometry data. The chemical structure of products 2 was that the 17-position of the thioester moiety of FLT was substituted by a carboxylic acid. The degradation product in 0.1 M NaOH:CH3CN=1:1 was found to be product 2 based on 1H NMR data. The degradation product in 0.05 M NaOH was considered to be product 2 based on the retention time of HPLC. These results are useful for detecting the degradation products of FLT by enzymes of the intestinal bacterial flora in the large intestine after dosing FLT as an enema.